Literature DB >> 8994894

Assessment of agitation.

J Cohen-Mansfield1.   

Abstract

Agitation is inappropriate verbal, vocal, or motor activity, which is common among older persons with dementia. Its assessment is complicated both by communication difficulties and by the complexity of the manifested behaviors. Three general approaches are used to assess agitation: informant ratings, observational methods, and technological devices. Within each category, several assessment instruments exist. The approaches differ as to time sampling, objectivity, and cost. Assessment of agitation in pharmacological studies should include consideration of the specific meaning to the agitated behavior for the older person and for the caregiver, along with an evaluation of the consequences of the behavior. At times, the agitated behavior seems to signal a specific need, and alternative methods for fulfilling that need should be considered. Evaluation studies of pharmacologic agents should include consideration of the impact of these agents on nontarget behaviors, as well as an awareness of the large intraperson and interperson variability in agitated behaviors.

Entities:  

Mesh:

Year:  1996        PMID: 8994894     DOI: 10.1017/s104161029600261x

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN: 1041-6102            Impact factor:   3.878


  14 in total

Review 1.  Determinants of behavioral and psychological symptoms of dementia: A scoping review of the evidence.

Authors:  Ann Kolanowski; Marie Boltz; Elizabeth Galik; Laura N Gitlin; Helen C Kales; Barbara Resnick; Kimberly S Van Haitsma; Amy Knehans; Jane E Sutterlin; Justine S Sefcik; Wen Liu; Darina V Petrovsky; Lauren Massimo; Andrea Gilmore-Bykovskyi; Margaret MacAndrew; Glenna Brewster; Vycki Nalls; Ying-Ling Jao; Naomi Duffort; Danny Scerpella
Journal:  Nurs Outlook       Date:  2017-06-16       Impact factor: 3.250

2.  [A comparison of special and traditional inpatient care of people with dementia].

Authors:  S Weyerer; M Schäufele; I Hendlmeier
Journal:  Z Gerontol Geriatr       Date:  2005-04       Impact factor: 1.281

Review 3.  Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?

Authors:  Damien Gallagher; Nathan Herrmann
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546

Review 4.  Pharmacological management of behavioral symptoms associated with dementia.

Authors:  Subramoniam Madhusoodanan; Mark Bryan Ting
Journal:  World J Psychiatry       Date:  2014-12-22

5.  What is the evidence to support the use of therapeutic gardens for the elderly?

Authors:  Mark B Detweiler; Taral Sharma; Jonna G Detweiler; Pamela F Murphy; Sandra Lane; Jack Carman; Amara S Chudhary; Mary H Halling; Kye Y Kim
Journal:  Psychiatry Investig       Date:  2012-05-22       Impact factor: 2.505

6.  Effect of person-centred care on antipsychotic drug use in nursing homes (EPCentCare): study protocol for a cluster-randomised controlled trial.

Authors:  Christin Richter; Almuth Berg; Steffen Fleischer; Sascha Köpke; Katrin Balzer; Eva-Maria Fick; Andreas Sönnichsen; Susanne Löscher; Horst Christian Vollmar; Burkhard Haastert; Andrea Icks; Charalabos-Markos Dintsios; Eva Mann; Ursula Wolf; Gabriele Meyer
Journal:  Implement Sci       Date:  2015-06-04       Impact factor: 7.327

7.  Implementation of a Multicomponent intervention to Prevent Physical Restraints In Nursing home residenTs (IMPRINT): study protocol for a cluster-randomised controlled trial.

Authors:  Jens Abraham; Ralph Möhler; Adrienne Henkel; Ramona Kupfer; Andrea Icks; Charalabos-Markos Dintsios; Burkhard Haastert; Gabriele Meyer; Sascha Köpke
Journal:  BMC Geriatr       Date:  2015-07-21       Impact factor: 3.921

8.  Multidimensional assessment of challenging behaviors in advanced stages of dementia in nursing homes-The insideDEM framework.

Authors:  Stefan Teipel; Christina Heine; Albert Hein; Frank Krüger; Andreas Kutschke; Sven Kernebeck; Margareta Halek; Sebastian Bader; Thomas Kirste
Journal:  Alzheimers Dement (Amst)       Date:  2017-04-04

9.  Item distribution and inter-rater reliability of the German version of the quality of life in Alzheimer's disease scale (QoL-AD) proxy for people with dementia living in nursing homes.

Authors:  Martin Nikolaus Dichter; Eva-Maria Wolschon; Christian G G Schwab; Gabriele Meyer; Sascha Köpke
Journal:  BMC Geriatr       Date:  2018-06-19       Impact factor: 3.921

10.  The efficacy of mirtazapine in agitated patients with Alzheimer's disease: A 12-week open-label pilot study.

Authors:  Sibel Cakir; Isin Baral Kulaksizoglu
Journal:  Neuropsychiatr Dis Treat       Date:  2008-10       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.